Emzadirib
Product Specifications
UNSPSC Description
Emzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1[1].
Target Antigen
RAD51
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emzadirib.html
Purity
99.63
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(OC(N[C@H]1CC[C@H](C2=NC=C(C3=CC=C(NC(OC(C)C)=O)C=C3S(=O)(NC(C)(C)C)=O)S2)CC1)=O)C
Molecular Weight
580.76
References & Citations
[1]Alfredo C. Castro, et al. Rad51 inhibitors. WO2019/051465A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111887/Emzadirib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111887/Emzadirib-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2301085-04-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal Prohibitin 2 Antibody [HRP]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS2073087-01 0.1 mL
FITC-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073087-02 0.2 mL
FITC-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073087-03 0.5 mL
FITC-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details 
MBS2073087-04 1 mL
FITC-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073087-05 5 mL
FITC-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details